Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis
Cardiovascular Research · 2023
DOI: 10.1093/cvr/cvac052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Paolo Carai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Myocarditis, Virus Diseases, Coxsackievirus Infections. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ERA-Net-CVD project MacroERA, Netherlands Organization for Scientific Research, FWO Krediet aan Navorser.
Abstract (Originalsprache)
Aims
Viral myocarditis (VM) is an inflammatory pathology of the myocardium triggered by a viral infection that may cause sudden death or heart failure (HF), especially in the younger population. Current treatments only stabilize and improve cardiac function without resolving the underlying inflammatory cause. The factors that induce VM to progress to HF are still uncertain, but neutrophils have been increasingly associated with the negative evolution of cardiac pathologies. The present study investigates the contribution of neutrophils to VM disease progression in different ways. Methods and results In a coxsackievirus B3- (CVB3) induced mouse model of VM, neutrophils and neutrophil extracellular traps (NETs) were prominent in the acute phase of VM as revealed by enzyme-linked immunosorbent assay analysis and immunostaining. Anti-Ly6G-mediated neutrophil blockade starting at model induction decreased cardiac necrosis and leucocyte infiltration, preventing monocyte and Ly6CHigh pro-inflammatory macrophage recruitment. Furthermore, genetic peptidylarginine deiminase 4-dependent NET blockade reduced cardiac damage and leucocyte recruitment, significantly decreasing cardiac monocyte and macrophage presence. Depleting neutrophils with anti-Ly6G antibodies at 7 days post-infection, after the acute phase, did not decrease cardiac inflammation.
Conclusion
Collectively, these results indicate that the repression of neutrophils and the related NET response in the acute phase of VM improves the pathological phenotype by reducing cardiac inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Vascular and Molecular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
- CARIM, Maastricht University, Maastricht, The Netherlands.
- Department of Cardiology, Experimental Cardiology Laboratory, Utrecht University, Utrecht, The Netherlands.
- Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy.
ORCID-Profile: Paolo Carai, Stijn Van Bruggen, Daria De Giorgio, Kimberly Martinod, Elizabeth Anne Vincent Jones, Stephane Heymans
Förderung
- ERA-Net-CVD project MacroERA
- Netherlands Organization for Scientific Research
- FWO Krediet aan Navorser
Zitieren
APA
Carai, P., González, L. F., Van Bruggen, S., Spalart, V., De Giorgio, D., Geuens, N., Martinod, K., Jones, E. A. V., & Heymans, S. (2023). Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvac052
Vancouver
Carai P, González LF, Van Bruggen S, Spalart V, De Giorgio D, Geuens N, et al. Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis. Cardiovascular Research. 2023. doi:10.1093/cvr/cvac052
BibTeX
@article{Carai2023,
author = {Carai, Paolo and González, Laura Florit and Van Bruggen, Stijn and Spalart, Valerie and De Giorgio, Daria and Geuens, Nadéche and Martinod, Kimberly and Jones, Elizabeth Anne Vincent and Heymans, Stephane},
title = {Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis},
journal = {Cardiovascular Research},
year = {2023},
doi = {10.1093/cvr/cvac052}
}
EUVIMED